Susquehanna International Group’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-875
Closed -$23.4K 12878
2024
Q1
$23.4K Buy
+875
New +$15.1K ﹤0.01% 11781
2023
Q4
Sell
-2,242
Closed -$34.7K 13013
2023
Q3
$34.7K Sell
2,242
-1,683
-43% -$32.1K ﹤0.01% 11432
2023
Q2
$84.8K Buy
3,925
+2,842
+262% +$56K ﹤0.01% 11066
2023
Q1
$19.2K Buy
+1,083
New +$20.9K ﹤0.01% 12065
2022
Q3
Sell
-15,483
Closed -$873K 13847
2022
Q2
$873K Buy
15,483
+11,758
+316% +$614K ﹤0.01% 6861
2022
Q1
$217K Sell
3,725
-3,142
-46% -$197K ﹤0.01% 11043
2021
Q4
$494K Buy
6,867
+234
+4% +$19.6K ﹤0.01% 9251
2021
Q3
$537K Sell
6,633
-10,242
-61% -$898K ﹤0.01% 9198
2021
Q2
$1.63M Buy
16,875
+9,133
+118% +$934K ﹤0.01% 6430
2021
Q1
$930K Sell
7,742
-5,666
-42% -$820K ﹤0.01% 7936
2020
Q4
$1.75M Buy
13,408
+3,683
+38% +$476K ﹤0.01% 5376
2020
Q3
$1.03M Buy
+9,725
New +$1.2M ﹤0.01% 6048

Other funds holding NXTC

Susquehanna International Group's NXTC Position: Q3 2025 in Review

Susquehanna International Group sold out of NextCure (NXTC) in Q3 2025, closing a stake of 2,459 shares — an estimated $13.6K sold.

Susquehanna International Group first reported a position in NXTC in Q4 2019 and held it in 12 quarters. The position peaked at $542K in Q4 2021. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Susquehanna International Group reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,459 NextCure shares in Q3 2025, an estimated $13.6K.
  • Susquehanna International Group first reported a position in NextCure in Q4 2019 and held it in 12 quarters.
  • Susquehanna International Group's NextCure position peaked at $542K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.